Published in
Royal Society of Chemistry, Biomaterials Science, 9(9), p. 3185-3208, 2021
DOI: 10.1039/d0bm01838d
Links
Tools
(r)HDL in theranostics: how do we apply HDL's biology for precision medicine in atherosclerosis management?
Journal article published in 2021 by
Kepa B. Uribe 
,
Asier Benito-Vicente ,
Cesar Martin ,
Francisco Blanco-Vaca ,
Noemi Rotllan
,
Asier Benito-Vicente ,
Cesar Martin ,
Francisco Blanco-Vaca ,
Noemi Rotllan
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
(r)HDL therapeutics has progressed a long way but has yet to produce fruitful results. Based on what has been learned and on the most innovative perspectives, a new generation of “smart” rHDL is emerging as an alternative for the management of CVD.